iShares Nasdaq US Biotechnology UCITS ETF

ISIN IE00BYXG2H39

 | 

WKN A2DWAW

TER
0.35% p.a.
Distribution policy
Accumulating
Replication
Sampling
Fund size
407 m
Holdings
224
 

Overview

Quote

Trade this ETF at your broker

Choose your broker
Ad
Broker tip: Trade this ETF for 0.00€ per Order at the Scalable broker or for free in a savings plan. Find out more

Description

The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
 
The ETF's TER (total expense ratio) amounts to 0.35% p.a.. The iShares Nasdaq US Biotechnology UCITS ETF is the cheapest ETF that tracks the Nasdaq Biotechnology index. The ETF replicates the performance of the underlying index by sampling technique (buying a selection of the most relevant index constituents). The dividends in the ETF are accumulated and reinvested in the ETF.
 
The iShares Nasdaq US Biotechnology UCITS ETF has 407m Euro assets under management. The ETF was launched on 19 October 2017 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Fund size
EUR 407 m
Total expense ratio
0.35% p.a.
Replication Physical (Optimized sampling)
Legal structure ETF
Strategy risk Long-only
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in EUR)
17.83%
Inception/ Listing Date 19 October 2017
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Fund Provider iShares
Tax data Bundesanzeiger
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Indextype Total return index
Swap counterparty -
Collateral manager Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank
Securities lending Yes
Securities lending counterparty Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the iShares Nasdaq US Biotechnology UCITS ETF.
Similar ETFs via ETF search
Similar ETFs via investment guides
How do you like our new ETF profile? Here you'll find our Questionnaire.

Holdings

Below you find information about the composition of the iShares Nasdaq US Biotechnology UCITS ETF.

Top 10 Holdings

Weight of top 10 holdings
out of 224
51.37%
VERTEX PHARMACEUTICALS ORD
9.02%
AMGEN INC
8.61%
REGENERON PHARMACEUTICALS INC
8.46%
GILEAD SCIENCES INC
7.55%
MODERNA INC
3.96%
ASTRAZENECA PLC ADR
3.81%
BIOGEN INC
3.68%
ILLUMINA INC
2.34%
ALNYLAM PHARMACEUTICALS ORD
2.23%
BIOMARIN PHARMACEUTICAL ORD
1.71%

Countries

United States
83.79%
Ireland
1.42%
Germany
1.05%
Other
13.74%

Sectors

Health Care
88.93%
Other
11.07%
As of 31/01/2024

ETF Savings plan offers

Here you can find information about the savings plan availability of the ETF. You can use the table to compare all savings plan offers for the selected savings rate.
 
Broker Rating Savings plan offer Brokerage fee More information
free of charge
free of charge
More info
free of charge
free of charge
More info
free of charge
free of charge
More info
free of charge
free of charge
More info
free of charge
free of charge
More info
Show all offers

Performance

Returns overview

YTD +4.03%
1 month +2.06%
3 months +12.93%
6 months +7.22%
1 year +5.69%
3 years +8.20%
5 years +32.00%
Since inception (MAX) +40.76%
2023 +0.53%
2022 -5.02%
2021 +7.94%
2020 +15.18%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 17.83%
Volatility 3 years 23.49%
Volatility 5 years 25.60%
Return per risk 1 year 0.32
Return per risk 3 years 0.11
Return per risk 5 years 0.22
Maximum drawdown 1 year -12.19%
Maximum drawdown 3 years -30.93%
Maximum drawdown 5 years -30.93%
Maximum drawdown since inception -30.93%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
gettex EUR 2B70 -
-
-
-
-
Stuttgart Stock Exchange EUR 2B70 -
-
-
-
-
Bolsa Mexicana de Valores MXN - BTEC1N MM
BTEC1N.MX
London Stock Exchange USD BTEC BTEC LN
INAVBTEU
BTEC.L
0WXSINAV.DE
London Stock Exchange GBP BTEK BTEK LN
INAVBTEU
BTEK.L
0WXSINAV.DE
SIX Swiss Exchange USD BTEC BTEC SE
INAVBTEU
BTEC.S
0WXSINAV.DE
XETRA EUR 2B70 2B70 GY
INAVBTEE
BTEC.DE
0WXNINAV.DE

Further information

Further ETFs on the Nasdaq Biotechnology index

Fund name Fund Size in m € (AuM) TER
in % p.a.
Distribution policy Replication method
Invesco Nasdaq Biotech UCITS ETF 598 0.40% p.a. Accumulating Swap-based
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 41 0.35% p.a. Distributing Sampling

Frequently asked questions

What is the name of 2B70?

The name of 2B70 is iShares Nasdaq US Biotechnology UCITS ETF.

What is the ticker of iShares Nasdaq US Biotechnology UCITS ETF?

The primary ticker of iShares Nasdaq US Biotechnology UCITS ETF is 2B70.

What is the ISIN of iShares Nasdaq US Biotechnology UCITS ETF?

The ISIN of iShares Nasdaq US Biotechnology UCITS ETF is IE00BYXG2H39.

What are the costs of iShares Nasdaq US Biotechnology UCITS ETF?

The total expense ratio (TER) of iShares Nasdaq US Biotechnology UCITS ETF amounts to 0.35% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is iShares Nasdaq US Biotechnology UCITS ETF paying dividends?

iShares Nasdaq US Biotechnology UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of iShares Nasdaq US Biotechnology UCITS ETF?

The fund size of iShares Nasdaq US Biotechnology UCITS ETF is 407m Euro. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.